Introduction Pneumococcal disease (PD) significantly contributes to morbidity and mortality,
carrying substantial economic and public health burden. This article is a targeted review of …

Introduction Guidelines recommend respiratory fluoroquinolone monotherapy or β-lactam
plus macrolide combination therapy as first-line options for hospitalized adults with mild to …

Background Glucocorticoids probably improve outcomes in patients hospitalised for
community acquired pneumonia (CAP). In this a priori planned exploratory subgroup …

The study was conducted from October 2020 to March 2022 in a province in southern
Thailand. The inpatients with community-acquired pneumonia (CAP) and more than 18 …

Introduction Community-acquired pneumonia has high mortality and is associated with
significant healthcare costs. In older adults with community-acquired pneumonia neutrophil …

Background/Objectives: Community-acquired pneumonia (CAP) is a common emergency
presentation in Australia, with the choice of admitting specialty unit often influenced by …

Introduction pneumococcal infections are associated with high morbidity, hospitalisation and
mortality. The objective of this study was to investigate the health and economic burden of all …

Introduction Current guidelines recommend pneumococcal vaccination in individuals who
are over the age of 65 or are immunosuppressed due to a disease or treatment. The …

Objetivo: Descrever os custos das internações por pneumonia no Ceará no período de
janeiro a dezembro de 2021 após estabilização dos casos da COVID-19. Métodos: Trata-se …

For most of its centuries-old history, acute pneumonia (AP) has been considered by
medicine as a single nosological form based on inflammation of the lung tissue and which …